Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

President Donald Trump has temporarily dropped tariff rates on imports for most U.S. trading partners to 10% for 90 days to ...

Pacific Biosciences of California backed its prior outlook and announced cuts to its spending and workforce, boosting shares even before the tariffs announcement. PacBio also said it is executing a ...

The American trade structure is witnessing a transformative shift, thanks to the Trump administration’s sweeping new tariff ...

Trump doubled down on plans to soon impose “major” pharmaceutical tariffs, while early stage startups dominated digital ...

Frank said that practices that administer drugs in the office, such as oncology, could see a huge hit when the cost of those ...

Some hospitals monitoring tariffs from President Donald Trump are raising concerns about supply shortages and higher costs ...

Taxing imports to the US could spell major consequences for health care prices, innovation, and access, as a great amount of ...

With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...

Jim Cramer in a latest program on CNBC said he’s bullish on Freeport-McMoRan Inc (NYSE:FCX) and talked about a potential ...

But the White House isn’t flinching — instead repeating its mantra that the trade barriers will help the U.S. economy in the ...

We take a look at the prime minister’s claim Dutton wanted to end bulk-billing and the Coalition’s claim grocery prices are ...